Application of ctDNA detection in non-invasive monitoring of early non-small cell lung cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054987

Enrollment

Unknown

Registered

2021-12-30

Start date

2021-12-31

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer (NSCLC)

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years, no gender limit; 2. Histologically assessed as clinical stage I-IIIA non-small cell lung cancer; 3. The presence of measurable lesions; 4. ECOG performance status score 0-1 points; 5. Radical resection can be performed; 6. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Accompanied by severe non-tumor disease; 2. The subject has a history of previous tumors (except for treated basal cell carcinoma of the skin and/or carcinoma in situ); 3. The subjects had undergone major surgery within 4 weeks before enrollment; 4. The subject is pregnant or breastfeeding.

Design outcomes

Primary

Measure	Time frame
circulating tumor DNA;	—

Countries

China

Contacts

Public ContactWang Wei

The First Affiliated Hospital of Nanjing Medical University

wangwei15261883958@163.com+86 15261883958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026